Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The STEP program encompasses five phase 3 trials that focus on the different aspects of weight management, including weight management in type 2 diabetes, weight management with intensive behavioral therapy, sustained weight management, and long-term weight management
[PMC free article] [PubMed] [Google Scholar]
The verdict Conditional on most plans Blue Shield of California restricts new Wegovy weight-loss starts to BMI 40 or higher (Class III/morbid obesity) since January 1, 2025 meaning patients at BMI 3039 who otherwise qualify under the FDA label are excluded from new weight-loss coverage
Until recently they have had little support from the two dominant GLP-1 drug makers, Novo Nordisk and Eli Lilly who have not considered addition a high prioroty (Sheridan)
Check blood sugar multiple times daily (typically 4 to 7 times)
